Septerna, Inc. - 8-K Filing
Septerna reports Q3 2026 revenue of $18.9 million and a net loss of $26.6 million, with cash reserves expected to last into mid-2029. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $SEPN
Read the full article at SEC EDGAR
Part of the story IDEAYA Biosciences, Inc. - 8-K Filing (42 articles)